Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation clinical trials

Explore recruiting advanced non small cell lung cancer with her2 erbb2 mutation clinical trials.

Recruiting advanced non small cell lung cancer with her2 erbb2 mutation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

(22615 SOHO-02) A Phase 3 open-label, randomized, active-controlled, multicenter trial to evaluate the efficacy and safety of orally administered BAY 2927088 compared with standard of care as a first-line therapy in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with HER2-activating mutations

Italy, Spain, France, Denmark, Greece, Finland +12 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation trials by city

Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation in Toronto Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation in Vancouver Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation in Montreal Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation in Calgary Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation in Edmonton Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation in Ottawa Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation in Winnipeg Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation in Quebec City Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation in Hamilton Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation in Kitchener Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation in London Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation in Halifax Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation in New York Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation in Los Angeles Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation in Chicago Advanced Non Small Cell Lung Cancer With Her2 Erbb2 Mutation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease